BMP Release
The bone morphogenetic protein (BMP) release assay measures the kinetics and amount of BMP elution from a biomaterial carrier over time. BMP-2, BMP-6, BMP-7, and BMP-9 are potent osteoinductive growth factors discovered by Marshall Urist in 1965 that trigger bone and cartilage formation. When loaded into scaffolds, hydrogels, or implants, BMPs must be released in a controlled manner to maximize biological effect while minimizing systemic exposure. The release assay quantifies how much BMP is present in the surrounding medium at defined timepoints, enabling optimization of carrier materials and release profiles for bone regeneration and fracture healing applications.
Source record
Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.
- Urist, M. R. (1965). Bone: formation by autoinduction. Science, 150(3698), 893-899. · DOI 10.1126/science.150.3698.893
- Reddi, A. H. (2001). Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: noggin, gremlin, and chordin. Arthritis Research, 3(1), 1-5. · URL
- Garrison, K. R., Donell, S., Reuben, A., et al. (2010). Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the management of fractures of long bones: a systematic review. The Journal of Bone and Joint Surgery, 89(4), 477-490. · URL
Curated claims
Claims persisted in the evidence ledger, each with its own assessment.
This view does not invent a claim assessment when the ledger has none.
Related methods
Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.